Chronic Myeloid Leukemia: A retrospective study of clinical and pathological features

Abstract

Chronic myeloid leukemia (CML), is one of the myeloproliferative disorders with a characteristic cytogenetic abnormality resulting in the BCR-ABL fusion gene. Imatinib Mesylate is an effective agent for treating patients in all stages of CML. According to the annual Iraqi cancer registry 2019, the total number of chronic myeloproliferative disorders was 338. The percentage and incidence rates were 0.94% and 0.86%, respectively, with a higher incidence rate in males than females (1.12 in males and 0.60 in females). In this registry, no details about CML, so this study aimed to estimate the number of CML patients who attended the national center of hematology from 2005 until 2020 and investigate their epidemiological and clinic-pathological data. All data were obtained from the National Center of Hematology /Baghdad. Data regarding annual admission, number of deaths, and information about age, regions, and sex, were collected from patient cards. Interview and history taking from the patient and reviewing their clinical features at diagnosis were performed, and then statistical analysis was achieved. Two hundred sixteen patients were registered as CML; among them, 163 are still alive, while 53 died. The mean age at diagnosis was 40.39 ±14.30, with a male-to-female ratio of 1:1.16. The pediatrics age group comprises 3.7% of total cases and 1.8 % and 9.4% in the alive and dead groups, respectively. The percentages of death were higher in the pediatric age group, 62,5%( 5 /8), followed by the patient group who were ≥60 years, 42.1%(8/19), while it was the least in adults < 60 years, 21.1% (40/189). In conclusion, the studied patients with CML were younger than the globally reported ages at diagnosis, with predominant female patients. Females had better survival, while children and the elderly were the worse. Most patients were symptomatic at diagnosis; however, a good outcome is achieved when treated with IM. Keywords: CML, Imatinib, leukemia,

Role of Vitamin D in the diagnosis of acute Myeloid Leukemia

“…So that vitamin D is an ideal test for diagnostic AML patients than calcium. Recently, cancer disease can be diagnosed by PCR, such as CML 34 and Adenocarcinoma 35,36 . This molecular technique was also employed to diagnosis different microorganisms that caused pathogenicity in human such as Clostridium perfringens 37 , Brucella melitensis 38 , Proteus vulgaris 39,40 , Staphylococcus aureus 41 , Pseudomonas aeruginosa 42,43 , and Toxoplasma spp 44,45 .…”

Genetic Association of Angiotensin-converting enzyme 2 ACE-2 (rs2285666) Polymorphism with the Susceptibility of COVID-19 Disease in Iraqi Patients

“…The molecular approach was used to diagnose many pathogens, including : Proteus vulgaris, 31,32 Clostridium perfringens, 33 Staphylococcus auras, 34,35,36 Brucella melitensis, 37 Pseudomonas spp, 38 Toxoplasma spp 39,40 and SARS-Cov-2. 41,42 Also, Chronic Myeloid Leukemia, 43 Adenocarcinoma, 44,45 and another cancers 46 ,were considered severe genetic illnesses and diagnostic by PCR was suggested. On other hand, the CT chest patterns were consider in COVID-19 diagnosis in some local studies.…”

A study of ATPase gene variants of mitochondrial DNA in patients with Type 2 diabetes mellitus

“…The PCR method has many medicinal uses, including the identification of MRSA (9), the genotyping and evaluation of some parameters in toxoplasmosis (10), the diagnosis of adenocarcinoma (11), Brucella melitensis (12), and Clostridium perfringens strains (13). Further, the PCR method can be applied to diagnosis of CML (14). The products were subjected to electrophoresis on 2% agarose gel, stained with ethidium bromide (0.5 μL) and the bands visualized under UV light.…”